File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-33745317580
- PMID: 16785567
- WOS: WOS:000238471400080
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2 /PGE4 receptors, protein kinase A, IκB kinase, and NF-κB
Title | Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE<inf>2</inf>/PGE<inf>4</inf> receptors, protein kinase A, IκB kinase, and NF-κB |
---|---|
Authors | |
Issue Date | 2006 |
Citation | Journal of Immunology, 2006, v. 177, n. 1, p. 681-693 How to Cite? |
Abstract | In this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages. PGN caused concentration- and time-dependent increases in IL-6, PGE2, and cAMP production. PGN-mediated IL-6 production was inhibited by a nonselective cyclooxygenase (COX) inhibitor (indomethacin), a selective COX-2 inhibitor (NS398), a PGE2 (EP2) antagonist (AH6809), a PGE4 (EP4) antagonist (AH23848), and a protein kinase A (PKA) inhibitor (KT5720), but not by a nonselective NO synthase inhibitor (NG-nitro-L-arginine methyl ester). Furthermore, PGE2, an EP2 agonist (butaprost), an EP2/PGE3 (EP3)/EP4 agonist (misoprostol), and misoprostol in the presence of AH6809 all induced IL-6 production, whereas an EP1/EP3 agonist (sulprostone) did not. PGN caused time-dependent activations of IκB kinase αβ (IKKdβ) and p65 phosphoryiation at Ser276, and these effects were inhibited by NS398 and KT5720. Both PGE2 and 8-bromo-cAMP also caused IKKdβ kinase αβ phosphorylation. PGN resulted in two waves of the formation of NF-κB-specific DNA-protein complexes. The first wave of NF-κB activation occurred at 10-60 min of treatment, whereas the later wave occurred at 2-12 h of treatment. The PGN-induced increase in κB luciferase activity was inhibited by NS398, AH6809, AH23848, KT5720, a protein kinase C inhibitor (Ro31-8220), and a p38 MAPK inhibitor (SB203580). These results suggest that PGN-induced IL-6 production involves COX-2-generated PGE2, activation of the EP2 and EP4 receptors, cAMP formation, and the activation of PKA, protein kinase C, p38 MAPK, IKKdβ, kinase αβ, p65 phosphorylation, and NF-κB. However, PGN-induced NO release is not involved in the signaling pathway of PGN-induced DL-6 production. Copyright © 2006 by The American Association of Immunologists, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/241138 |
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 1.558 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Bing Chang | - |
dc.contributor.author | Liao, Chiao Chun | - |
dc.contributor.author | Hsu, Ming Jen | - |
dc.contributor.author | Liao, Yi Ting | - |
dc.contributor.author | Lin, Chia Chin | - |
dc.contributor.author | Sheu, Joen Rong | - |
dc.contributor.author | Lin, Chien Huang | - |
dc.date.accessioned | 2017-05-26T03:36:55Z | - |
dc.date.available | 2017-05-26T03:36:55Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Journal of Immunology, 2006, v. 177, n. 1, p. 681-693 | - |
dc.identifier.issn | 0022-1767 | - |
dc.identifier.uri | http://hdl.handle.net/10722/241138 | - |
dc.description.abstract | In this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages. PGN caused concentration- and time-dependent increases in IL-6, PGE2, and cAMP production. PGN-mediated IL-6 production was inhibited by a nonselective cyclooxygenase (COX) inhibitor (indomethacin), a selective COX-2 inhibitor (NS398), a PGE2 (EP2) antagonist (AH6809), a PGE4 (EP4) antagonist (AH23848), and a protein kinase A (PKA) inhibitor (KT5720), but not by a nonselective NO synthase inhibitor (NG-nitro-L-arginine methyl ester). Furthermore, PGE2, an EP2 agonist (butaprost), an EP2/PGE3 (EP3)/EP4 agonist (misoprostol), and misoprostol in the presence of AH6809 all induced IL-6 production, whereas an EP1/EP3 agonist (sulprostone) did not. PGN caused time-dependent activations of IκB kinase αβ (IKKdβ) and p65 phosphoryiation at Ser276, and these effects were inhibited by NS398 and KT5720. Both PGE2 and 8-bromo-cAMP also caused IKKdβ kinase αβ phosphorylation. PGN resulted in two waves of the formation of NF-κB-specific DNA-protein complexes. The first wave of NF-κB activation occurred at 10-60 min of treatment, whereas the later wave occurred at 2-12 h of treatment. The PGN-induced increase in κB luciferase activity was inhibited by NS398, AH6809, AH23848, KT5720, a protein kinase C inhibitor (Ro31-8220), and a p38 MAPK inhibitor (SB203580). These results suggest that PGN-induced IL-6 production involves COX-2-generated PGE2, activation of the EP2 and EP4 receptors, cAMP formation, and the activation of PKA, protein kinase C, p38 MAPK, IKKdβ, kinase αβ, p65 phosphorylation, and NF-κB. However, PGN-induced NO release is not involved in the signaling pathway of PGN-induced DL-6 production. Copyright © 2006 by The American Association of Immunologists, Inc. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Immunology | - |
dc.title | Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE<inf>2</inf>/PGE<inf>4</inf> receptors, protein kinase A, IκB kinase, and NF-κB | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.pmid | 16785567 | - |
dc.identifier.scopus | eid_2-s2.0-33745317580 | - |
dc.identifier.volume | 177 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 681 | - |
dc.identifier.epage | 693 | - |
dc.identifier.isi | WOS:000238471400080 | - |
dc.identifier.issnl | 0022-1767 | - |